Table 3.
Banff scores in the first and second surveillance biopsies (n = 85).
| Variable | First Biopsy | Second Biopsy | p-Value |
|---|---|---|---|
| Glomerular sections (n) | 13 ± 8 | 13 ± 8 | 0.881 |
| Global glomerulosclerosis (%) | 7 ± 10 | 8 ± 11 | 0.541 |
| Glomerulitis (g) | 0.12 ± 0.36 | 0.15 ± 0.45 | 0.580 |
| Interstitial infiltrate (i) | 0.27 ± 0.54 | 0.17 ± 0.37 | 0.118 |
| Tubulitis (t) | 0.18 ± 0.42 | 0.31 ± 0.58 | 0.086 |
| Endothelialitis (v) | 0.01 ± 0.11 | 0 | 0.320 |
| Peritubular capillaritis (ptc) | 0.13 ± 0.37 | 0.18 ± 0.47 | 0.413 |
| Arteriolar hyalinosis (ah) | 0.38 ± 0.64 | 0.65 ± 0.79 | 0.008 |
| Transplant glomerulopathy (cg) | 0 | 0.04 ± 0.24 | 0.183 |
| Interstitial fibrosis (ci) | 0.73 ± 0.77 | 1.00 ± 0.84 | 0.002 |
| Tubular atrophy (ct) | 0.76 ± 0.59 | 1.08 ± 0.73 | 0.001 |
| Vascular intimal thickening (cv) | 0.62 ± 0.91 | 0.67 ± 0.85 | 0.636 |
| Mesangial matrix increase (mm) | 0.02 ± 0.15 | 0.01 ± 0.11 | 0.567 |
| i-IFTA | 1.28 ± 1.17 | 1.39 ± 1.21 | 0.494 |
| t-IFTA | 0.36 ± 0.55 | 0.51 ± 0.67 | 0.128 |
i-IFTA. Interstitial inflammation in areas of interstitial fibrosis and tubular atrophy; t-IFTA, tubulitis in areas of interstitial fibrosis and tubular atrophy.